Screening and prevention of diabetic blindness

Acta Ophthalmologica Scandinavica

Volumn 78, Issue 4, 2000, Pages 374-385

  Stefánsson, Einar ^a   Bek, Toke ^b   Porta, Massimo ^c   Larsen, Nikolaj ^d   Kristinsson, Jóhannes Kári ^a,f   Agardh, Elisabet ^e  

^a UNIVERSITY OF ICELAND   (Iceland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF TURIN   (Italy)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Blindness; Diabetes mellitus; Diabetic retinopathy; Laser treatment; Medical economics; Preventive medicine; Public health; Screening; Telemedicine

Indexed keywords

ARTICLE; BLINDNESS; CAMERA; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE PHOTOGRAPHY; HIGH RISK PATIENT; HUMAN; LASER SURGERY; MEDICAL RECORD; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA EDEMA; SCREENING; TECHNOLOGY; TIME; TREATMENT OUTCOME;

BLINDNESS; DIABETES COMPLICATIONS; DIABETIC RETINOPATHY; ECONOMICS, MEDICAL; EUROPE; HUMANS; INCIDENCE; LASER COAGULATION; PREVALENCE; PREVENTIVE MEDICINE; VISION SCREENING; WISCONSIN;

EID: 0033867261     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.2000.078004374.x     Document Type: Article

References (84)

1. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy
2. The importance of early diagnosis of treatable diabetic retinopathy for the four-year visual outcome in type 2 diabetes mellitus
3. Diabetic retinopathy
4. New blindness in diabetes reduced by more than one-third in Stockholm County
5. The National Diabetic Retinopathy Laser Treatment Audit. I
6. The National Diabetic Retinopathy Laser Treatment Audit. II
7. Image processing as a tool for diabetic retinopathy screening. Background, problems, and present status
8. Patienttilfredshed ved screening for diabetisk retinopati pa en hospitalsafdeling
9. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study
10. Introduction: Principles of screening
11. Cost-effectiveness of strategies for detecting diabetic retinopathy
12. Preliminary report on effects of photocoagulation therapy
13. Colour photography vs. fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial
14. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
15. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial
16. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus
17. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial
18. A modification of the Airlie House classification of diabetic retinopathy
19. Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings
20. Factors influencing the development of visual loss in advanced diabetic retinopathy
21. Indications for photocoagulation treatment of diabetic retinopathy
22. Causes of blindness in the Netherlands
23. Photocoagulation for diabetic macular edema
24. Grading diabetic retinopathy from stereoscopic colour fundus photographs - An extension of the modified Airlie house classification
25. Detection of abnormalities in retinal images using digital image analysis
26. Teleoftalmologi
27. Diabetic retinopathy in the West of Scotland: Its detection and prevalence, and the cost-effectiveness of a proposed screening programme
28. Automatic detection of diabetic retinopathy using an artifical neural network: A screening tool
29. Common causes of blindness and visual handicap in the West of Scotland
30. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: The Liverpool diabetic eye study
31. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control
32. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme
33. Cost effectiveness of current approaches to the control of retinopathy in type 1 diabetics
34. Detecting and treating retinopathy in patients with type 1 diabetes mellitus. A health policy model
35. Detecting and treating retinopathy in patients with type 1 diabetes mellitus: Savings associated with improved implementation of current guidelines
36. Preventive eye care in people with diabetes is cost-saving to the Federal government
37. Use of preventive eye care by Americans with diabetes; Compliance with Diabetes 2000 objectives
38. Cost savings associated with detection and treatment of diabetic eye disease
39. Cost-effectiveness of detecting and treating diabetic retinopathy
40. Visual acuity in a diabetic population
41. Prevalence of diabetic retinopathy
42. Blindness caused by diabetic retinopathy
43. Nonstereo fundus photography as a screening procedure for diabetic retinopathy among patients with type II diabetes compared with 60D enhanced slit-lamp examination
44. The Wisconsin Epidemiological Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years
45. The Wisconsin Epidemiological Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years
46. Visual impairment in diabetes
47. The Wisconsin Epidemiological Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years
48. The Wisconsin Epidemiological Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more
49. The Wisconsin epidemiologic study of diabetic retinopathy. VI. Retinal photocoagulation
50. Epidemiology of proliferative diabetic retinopathy
51. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus
52. The relation of socio-economic factors to the incidence of proliferative diabetic retinopathy and loss of vision
53. Systematic screening for diabetic eye disease in insulin dependent diabetes
54. Screening for diabetic retinopathy. How soon, how often
55. Diabetic retinopathy. Screening and prevention of blindness
56. Active prevention in diabetic eye disease
57. Blindness incidence in Germany. A population-based study from Wurttemberg-Hohenzollern
58. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
59. Telescreening fur die diabetische Retinopathie
60. Comparison between ophthalmoscopy and fundus photography in determining the severity of diabetic retinopathy
61. The incidence of vision loss in a diabetic population
62. The 14-year incidence of visual loss in a diabetic population
63. The prevalence and causes of impaired vision in diabetics
64. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year cohort study of diabetes mellitus
65. Diabetic retinopathy II. The course of retinopathy in diabetics treated with oral hypoglycaemic agent and diet regime alone. A one year cohort study of diabetes mellitus
66. Evaluation of digital imaging for the telescreening for diabetic retinopathy
67. A comparison of the cost-effectiveness of three approaches to screen for sight-threatening diabetic retinopathy
68. Retinopathy Working Party (RWP) A protocol for screening for diabetic retinopathy in Europe
69. Prevention of blindness by screening for diabetic retinopathy: A quantitative assessment
70. Screening for diabetic retinopathy
71. Automated localisation of the optic disc, fovea and retinal blood vessels from digital colour fundus images
72. Blindness in insulin treated diabetic patients with age at onset <30 years
73. Incidence of blindness in relation to diabetes. A population-based study
74. Telemedicine and computers in diabetic retinopathy screening
75. Ophthalmic care for persons with diabetes